Unpacking Ozempic: The Debate on Health, Hype, and Disability
Ozempic was developed with the intent to treat type 2 diabetes, but today, it’s become one of the biggest weight-loss crazes in North America. Nisreen Abdel-Majid digs into what happens when a medication meant to save lives becomes a massive cultural trend, who it affects, and how severely. We hear from Mousa Abdul Samar, Pharmacist and Manager at Deen Pharmacy, who offers a vital perspective on Ozempic’s intended use and the risks of misuse. Bill Shakleton, a retired AMI colleague living with type 2 diabetes, shares his personal journey with the drug and how the weight-loss buzz affects him…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.